BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 31128293)

  • 1. Delivery of siRNA using folate receptor-targeted pH-sensitive polymeric nanoparticles for rheumatoid arthritis therapy.
    Sun X; Dong S; Li X; Yu K; Sun F; Lee RJ; Li Y; Teng L
    Nanomedicine; 2019 Aug; 20():102017. PubMed ID: 31128293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual-functional lipid polymeric hybrid pH-responsive nanoparticles decorated with cell penetrating peptide and folate for therapy against rheumatoid arthritis.
    Zhao J; Zhang X; Sun X; Zhao M; Yu C; Lee RJ; Sun F; Zhou Y; Li Y; Teng L
    Eur J Pharm Biopharm; 2018 Sep; 130():39-47. PubMed ID: 29928978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo therapeutic efficacy of TNFα silencing by folate-PEG-chitosan-DEAE/siRNA nanoparticles in arthritic mice.
    Shi Q; Rondon-Cavanzo EP; Dalla Picola IP; Tiera MJ; Zhang X; Dai K; Benabdoune HA; Benderdour M; Fernandes JC
    Int J Nanomedicine; 2018; 13():387-402. PubMed ID: 29391796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of double-targeting nanoparticles loaded with MCL-1 siRNA and dexamethasone for adjuvant-induced arthritis therapy.
    Li X; Yu C; Meng X; Hou Y; Cui Y; Zhu T; Li Y; Teng L; Sun F; Li Y
    Eur J Pharm Biopharm; 2020 Sep; 154():136-143. PubMed ID: 32681961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of NF-kB targeted siRNA and methotrexate in a hybrid nanocarrier towards the effective treatment in rheumatoid arthritis.
    Duan W; Li H
    J Nanobiotechnology; 2018 Jul; 16(1):58. PubMed ID: 30060740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipidoid-polymer hybrid nanoparticles loaded with TNF siRNA suppress inflammation after intra-articular administration in a murine experimental arthritis model.
    Jansen MAA; Klausen LH; Thanki K; Lyngsø J; Skov Pedersen J; Franzyk H; Nielsen HM; van Eden W; Dong M; Broere F; Foged C; Zeng X
    Eur J Pharm Biopharm; 2019 Sep; 142():38-48. PubMed ID: 31199978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI-assessed therapeutic effects of locally administered PLGA nanoparticles loaded with anti-inflammatory siRNA in a murine arthritis model.
    te Boekhorst BC; Jensen LB; Colombo S; Varkouhi AK; Schiffelers RM; Lammers T; Storm G; Nielsen HM; Strijkers GJ; Foged C; Nicolay K
    J Control Release; 2012 Aug; 161(3):772-80. PubMed ID: 22580113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifunctional folate receptor-targeting and pH-responsive nanocarriers loaded with methotrexate for treatment of rheumatoid arthritis.
    Zhao J; Zhao M; Yu C; Zhang X; Liu J; Cheng X; Lee RJ; Sun F; Teng L; Li Y
    Int J Nanomedicine; 2017; 12():6735-6746. PubMed ID: 28932117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of folate-conjugated glycol-chitosan nanoparticles in modulating the activated macrophages to ameliorate inflammatory arthritis: in vitro and in vivo activities.
    Kumar V; Leekha A; Kaul A; Mishra AK; Verma AK
    Drug Deliv Transl Res; 2020 Aug; 10(4):1057-1075. PubMed ID: 32363539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient and Tumor Targeted siRNA Delivery by Polyethylenimine-graft-polycaprolactone-block-poly(ethylene glycol)-folate (PEI-PCL-PEG-Fol).
    Liu L; Zheng M; Librizzi D; Renette T; Merkel OM; Kissel T
    Mol Pharm; 2016 Jan; 13(1):134-43. PubMed ID: 26641134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipidoid-siRNA Nanoparticle-Mediated IL-1β Gene Silencing for Systemic Arthritis Therapy in a Mouse Model.
    Song P; Yang C; Thomsen JS; Dagnæs-Hansen F; Jakobsen M; Brüel A; Deleuran B; Kjems J
    Mol Ther; 2019 Aug; 27(8):1424-1435. PubMed ID: 31153827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted decationized polyplexes for siRNA delivery.
    Novo L; Takeda KM; Petteta T; Dakwar GR; van den Dikkenberg JB; Remaut K; Braeckmans K; van Nostrum CF; Mastrobattista E; Hennink WE
    Mol Pharm; 2015 Jan; 12(1):150-61. PubMed ID: 25384057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fabrication of self-assembled folate-biotin-quaternized starch nanoparticles as co-carrier of doxorubicin and siRNA.
    Li L; Tao R; Song M; Zhang Y; Chen K; Wang H; Gong R
    J Biomater Appl; 2017 Nov; 32(5):587-597. PubMed ID: 29073804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. pH-responsive complexes using prefunctionalized polymers for synchronous delivery of doxorubicin and siRNA to cancer cells.
    Dong DW; Xiang B; Gao W; Yang ZZ; Li JQ; Qi XR
    Biomaterials; 2013 Jul; 34(20):4849-59. PubMed ID: 23541420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folate-decorated hydrophilic three-arm star-block terpolymer as a novel nanovehicle for targeted co-delivery of doxorubicin and Bcl-2 siRNA in breast cancer therapy.
    Qian J; Xu M; Suo A; Xu W; Liu T; Liu X; Yao Y; Wang H
    Acta Biomater; 2015 Mar; 15():102-16. PubMed ID: 25545322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic delivery of small interfering RNA targeting nuclear factor κB in mice with collagen-induced arthritis using arginine-histidine-cysteine based oligopeptide-modified polymer nanomicelles.
    Kanazawa T; Endo T; Arima N; Ibaraki H; Takashima Y; Seta Y
    Int J Pharm; 2016 Dec; 515(1-2):315-323. PubMed ID: 27765724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyaluronic Acid Coated Acid-Sensitive Nanoparticles for Targeted Therapy of Adjuvant-Induced Arthritis in Rats.
    Yu C; Li X; Hou Y; Meng X; Wang D; Liu J; Sun F; Li Y
    Molecules; 2019 Jan; 24(1):. PubMed ID: 30609724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNF-α gene silencing using polymerized siRNA/thiolated glycol chitosan nanoparticles for rheumatoid arthritis.
    Lee SJ; Lee A; Hwang SR; Park JS; Jang J; Huh MS; Jo DG; Yoon SY; Byun Y; Kim SH; Kwon IC; Youn I; Kim K
    Mol Ther; 2014 Feb; 22(2):397-408. PubMed ID: 24145554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Notch1 targeting siRNA delivery nanoparticles for rheumatoid arthritis therapy.
    Kim MJ; Park JS; Lee SJ; Jang J; Park JS; Back SH; Bahn G; Park JH; Kang YM; Kim SH; Kwon IC; Jo DG; Kim K
    J Control Release; 2015 Oct; 216():140-8. PubMed ID: 26282098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
    Li TS; Yawata T; Honke K
    Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.